Avoid common mistakes on your manuscript.
To the Editor,
We read with interest the article by Dr. Donati on residual paralysis1 and the accompanying editorial.2 The author effectively summarizes the rationale for documenting complete (near-complete) recovery from neuromuscular blockade and also points out that residual paralysis continues to occur frequently and likely increases perioperative complications. We don’t necessarily view this as a deficiency of knowledge in the field but as a failure to implement what is known. It has been recognized for some time and published in major anesthesia texts that “normal respiratory and upper airway function does not return to normal unless the train of four ratio at the adductor pollicis is 0.9 or more”.3 As Dr. Donati points out, it is also understood that the twitch should be assessed at the adductor pollicis, not at the corrugator supercilii. This failure to implement “expert knowledge” is not unique to anesthesiologists. It is well recognized that implementation of evidence-based practice can take years to disseminate both inside and outside the field of medicine.4 Many “expert” recommendations have been reversed, including many that affect anesthesiologists, such as perioperative blockade and tight glycemic control, and these changes of opinion likely create skepticism. In addition to the reasons cited in the editorial for failure to achieve complete reversal, including lack of knowledge, skepticism, and technical issues, we consider production pressure to be another reason why tracheal extubation is performed before the patient has achieved a train-of-four ratio (TOFR) > 0.9. In cases that require deep neuromuscular blockade during the procedure, e.g., laparoscopy, it may be very difficult with current reversal agents to achieve complete recovery in the short period of time it takes to close the port-site wounds and wake the patient. As such, the options are 1) to prolong tracheal intubation with the patient in the recovery room; 2) to wait until the TOFR is 0.9, thereby “delaying” the next case; or 3) to perform tracheal extubation when the patient “seems ready”, which is typically based on subjective measures such as tidal volume and head lift. Most anesthesiologists support use of the third option sensing that they don’t see problems related to residual neuromuscular blockade in the postanesthesia care unit.5 The risk to the patient will likely be reduced over time through increased education and awareness as well as availability of drugs with rapid reliable reversal of paralysis. We applaud the authors for their efforts in this regard.
Reply,
Drs Caruso and Urdaneta clearly identify two barriers associated with knowledge transfer into clinical practice, namely, deficiency of knowledge, and failure to implement what is known. Regarding residual neuromuscular blockade, they consider the knowledge base to be well established and convincing; consequently, the problem appears to be failure on the part of individual practitioners to apply that knowledge in everyday practice. Production pressure is identified as the driving force behind the lack of uniform adherence to recommendations, with the result that patients may undergo tracheal extubation with inadequate reversal of paralysis. Fortunately, most patients will cope without too much harm, with the symptoms of weakness1 and a prolonged stay in the recovery room2 recognized as minor side effects. Unfortunately, a small proportion of patients might have major adverse events, such as aspiration, hypoxia, and respiratory failure. Failure to comply with good clinical practices might be regarded as refraining from buying insurance: in most cases, it appears profitable because nothing serious happens; however, the situation might be catastrophic if unlikely but serious events do occur.
François Donati, MD, PhD
Department of Anesthesiology, Université de Montréal and Hôpital Maisonneuve-Rosemont, Montreal, QC, Canada
E-mail: francois.donati@umontreal.ca
References
Murphy GS, Szokol JW, Avram MJ, et al. Intraoperative acceleromyography monitoring reduces symptoms of muscle weakness and improves quality of recovery in the early postoperative period. Anesthesiology 2011; 115: 946-54.
Butterly A, Bittner EA, George E, Sandberg WS, Eikermann M, Schmidt U. Postoperative residual curarization from intermediate-acting neuromuscular blocking agents delays recovery room discharge. Br J Anaesth 2010; 105: 304-9.
Donati F. Residual paralysis: a real problem or did we invent a disease? Can J Anesth 2013; 60: 714-29.
Plaud B. Neuromuscular monitoring, residual blockade, and reversal: time for re-evaluation of our clinical practice. Can J Anesth 2013; 60: 634-40.
Donati F, Bevan DR. Neuromuscular blocking agents. In: Barash PG, Cullen BF, Stoelting RK (Eds). Clinical Anesthesia - Fifth Edition. Lippincott Williams & Wilkins; 2005.
Berwick DM. Disseminating innovations in health care. JAMA 2003; 289: 1969-75.
Naguib M, Kopman AF, Lien CA, Hunter JM, Lopez A, Brull SJ. A survey of current management of neuromuscular block in the United States and Europe. Anesth Analg 2010; 111: 110-9.
Funding
Funding provided by the Department of Anesthesiology, University of Florida College of Medicine.
Conflict of interest
There are no affiliations that are or may be perceived to be a conflict of interest and no other associations such as consultancies.
Conflicts of interest
None declared.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Caruso, L., Urdaneta, F. Adequate confirmation of recovery from neuromuscular blockade: What are the obstacles?. Can J Anesth/J Can Anesth 61, 82–83 (2014). https://doi.org/10.1007/s12630-013-0053-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12630-013-0053-1